Reliable In Vivo Platforms for Neurological Drug Development
CNS Pharmacology Models
Why Medicilon’s CNS Pharmacology Models Stand Out
Medicilon’s CNS pharmacology platform provides a comprehensive portfolio of validated in vivo models to support preclinical drug discovery targeting central nervous system (CNS) disorders. From neurodegenerative diseases like Alzheimer’s and Parkinson’s to psychiatric conditions such as depression and anxiety, our models are designed to replicate clinical symptoms, behavioral changes, and treatment response, enabling early and informed decision-making in your drug development pipeline.
Medicilon integrates behavioral analysis, biomarker detection, and histopathological evaluation to deliver translational data with high reproducibility and accelerated timelines.
Multiple Species
Mouse and Rat models adaptable for various CNS indication.
Flexible Study Duration
Acute and Chronic induction protocols.
Standardized Behavioral Paradigms
Reproducible test systems across multiple endpoints.
Biomarker & Histopathology Services
Comprehensive tissue and fluid-based analysis.
High-Quality Data Reports
Actionable, reproducible data to inform go/no-go decisions.
Extensive CNS Disease Models
Medicilon offers a diverse selection of CNS Disease Models providing reliable in vivo platforms for your neurological drug development
CNS Disease Models:
CNS Disorder
Model Description
Readouts / Tests
- Alzheimer’s Disease
Morris Water Maze, Cognition Wall Test, Pathological Examination
- Parkinson’s Disease
Rotarod, Pole Climb, Grip Strength, Histopathology
- Anxiety
Elevated Plus Maze, Open Field Test, Light-Dark Shuttle
- Depression
Immobility Time, Sugar Water Preference Test
Accelerate Your CNS Drug Development with Confidence
Whether you’re optimizing a neuroactive compound, validating a therapeutic mechanism, or seeking proof-of-concept efficacy, Medicilon delivers reliability, scientific depth, and flexibility at every stage.
- 20 Years of Excellence in preclinical CRO services
- Expertise in CNS pathophysiology and behavioral neuroscience
- Rapid Turnaround with complete data support
- End-to-End Integration from model establishment to IND-enabling studies
Tumor Models
Non-tumor Models
cancer therapy INNOVATION
Beyond Orthotopic Models, A Full-Spectrum Oncology Research Suite
Tumor models:
Medicilon provides a comprehensive range of oncology models, including:
- CDX Models – Fast, reliable tumor models for early-phase drug screening.
- PDX Models – Clinically relevant models for personalized medicine research.
- Syngeneic Mouse Models – Immunocompetent tumor models for evaluating novel cancer therapies in a controlled setting.
- Humanized Mouse Models – Bridge the gap between preclinical and clinical immunotherapy studies.
This holistic approach ensures that researchers can seamlessly transition from early drug discovery to translational research, accelerating the path to clinical trials.
